QC Kinetix Hosts Inaugural Medical Conference, Showcasing Clinical Depth and Innovation in Regenerative Orthobiologics

CHARLOTTE, N.C., Oct. 30, 2025 /PRNewswire/ -- QC Kinetix (QCK), a national leader in regenerative medicine and non-surgical orthobiologic care, proudly hosted its first annual QC Kinetix Medical Conference, bringing together physicians and providers from across the country for a day of advanced clinical education, collaboration and innovation.

The conference marked a defining moment for the organization, underscoring QCK's unwavering commitment to clinical excellence, scientific rigor, and standardization across its growing national network. Led by members of the Medical Management Team – including leaders in innovation, research, and medical operations – the event set a new benchmark for regenerative medicine education within a medical franchise model.

"The QC Kinetix National Medical conference was truly a dream come true for me, as a founder, and for the Medical Management Team overall," said Dr. Richard Schaffer, Co-Founder and Board Member for QC Kinetix. "Our team assembled and presented a detailed, recurring review of science-backed regenerative medicine, our procedures, and outcomes to our entire system of medical providers. A conference like this will keep our system of providers continually educated each year on this innovative and exciting field in medicine, allowing us to deliver the very best care for our patients."

The day began with a welcome from QCK's National Medical Director, Dr. Mitchell Sheinkop, who introduced attendees to the teams driving QCK's medical advancement behind the scenes. He described the ongoing work that drives QCK's leadership in regenerative medicine – the continuous evaluation of new orthobiologic advancements, refinement of treatment protocols, and steadfast commitment to evidence-based decision-making. Dr. Richard Schaffer reflected on QCK's journey and its vision for the future, highlighting how the organization's national expansion is creating broader access to high-quality regenerative care for patients everywhere.

"The first QC Kinetix Medical Conference represented a turning point for our network," said Dr. Ashley Caravelli, DO, Medical Director for QC Kinetix Chicagoland. "It was a day where we elevated provider education, reinforced clinical standards, and redefined what excellence in regenerative medicine looks like."

Throughout the day, the QCK Medical Conference offered a dynamic blend of science, technique, and application — covering the full spectrum of regenerative orthobiologics from platelet-rich plasma (PRP) and the importance of platelet dosing to shockwave and laser therapies. Attendees observed a live bone marrow aspiration and concentrate (BMAC) procedure, designed to standardize every step of processing and reinjection across the national network. This real-time demonstration elevated the learning experience beyond traditional presentations, allowing providers to see precise technique, handling, and communication standards in action. Complementary sessions on contraindications, imaging utilization, and FDA regulatory updates reinforced QCK's evidence-based framework, while interactive discussions on ultrasound guidance, protocol optimization, and lab processing deepened providers' understanding of both the cellular science and procedural precision that define optimal patient outcomes.

"The QC Kinetix Medical Conference was an outstanding and valuable experience for me and my team," said Dr. Sander Fernandez, MD,Medical Director for QC Kinetix South Florida. "The sessions provided excellent resources and practical knowledge that will directly benefit our practice — particularly in ultrasound and anatomy — as we continue advancing toward becoming a fully ultrasound-guided injection clinic."

As regenerative medicine grows in visibility, the conference reinforced that QC Kinetix is not only keeping pace with the science – it's helping define it. By uniting providers under one standardized, medically robust framework, QC Kinetix continues to dispel misconceptions and raise the bar for clinical competency in orthobiologic care.

QC Kinetix is proud to lead the way in regenerative medicine, combining innovation, compliance, and patient-focused care to deliver results backed by data and experience.

About QC Kinetix
Founded in 2017 and based in Charlotte, North Carolina, QC Kinetix is the largest regenerative medicine franchise in North America, recognized by the Inc. 5000 as one of America's fastest-growing private companies. The brand delivers non-surgical, biologic-based treatments to help patients address joint pain, injuries, and musculoskeletal conditions by stimulating the body's natural healing processes. QC Kinetix began franchising in 2020 and now operates more than 100 clinics across the U.S., with plans for 350 nationwide.

SOURCE QC Kinetix